📖👇
🖋️Singh Y,Reddy M, Papanicolas I and Scheffler R (2026).
Private equity investments inhealth care in OECD countries: an exploratory analysis.
Health Economics,Policy and Law 1–28. @CambridgeCore
🌐Open access 🔽
📖👇
🖋️Singh Y,Reddy M, Papanicolas I and Scheffler R (2026).
Private equity investments inhealth care in OECD countries: an exploratory analysis.
Health Economics,Policy and Law 1–28. @CambridgeCore
🌐Open access 🔽
📖Andronis, L., Morgan, C., Donaldson, C., Lancsar, E., & Petrou, S. (2026).
Accounting for the Opportunity Cost of Children's Time in Economic Evaluation: Challenges and Frequently Asked Questions.
@HECJournal 35(6), 995–1004.
📖Andronis, L., Morgan, C., Donaldson, C., Lancsar, E., & Petrou, S. (2026).
Accounting for the Opportunity Cost of Children's Time in Economic Evaluation: Challenges and Frequently Asked Questions.
@HECJournal 35(6), 995–1004.
via @HECJournal
Open Access.
✒️Zhao, T., Meacock, R., & Sutton, M. (2026).
📖Scale, Skill-Mix, and Access Implications of the Production of Appointments by Primary Care Practices in England.
Health economics, 35(3), 423–438.
🌐👇
via @HECJournal
Open Access.
✒️Zhao, T., Meacock, R., & Sutton, M. (2026).
📖Scale, Skill-Mix, and Access Implications of the Production of Appointments by Primary Care Practices in England.
Health economics, 35(3), 423–438.
🌐👇
#ReferenciasAES
@HECJournal
🖋️Serra-Sastre, V., Pinilla, J., & Kalansooriya, W. (2026).
📖 The Mental Health Impact of the COVID-19 Pandemic on Health and Social Care Workers.
Health economics, 10.1002/hec.70090.
Open access 🌐👇
https://f.mtr.cool/syacfdkvfi
🧵🔽
#ReferenciasAES
@HECJournal
🖋️Serra-Sastre, V., Pinilla, J., & Kalansooriya, W. (2026).
📖 The Mental Health Impact of the COVID-19 Pandemic on Health and Social Care Workers.
Health economics, 10.1002/hec.70090.
Open access 🌐👇
https://f.mtr.cool/syacfdkvfi
🧵🔽
Via @HECJournal
🖋️Frech, H. E., 3rd, Pauly, M. V., Comanor, W. S., & Martinez, J. R. (2026).
👉Pharmaceutical Pricing and R&D as a Global Public Good.
Health economics, 10.1002/hec.70105.
🌐🔽
https://f.mtr.cool/sltzlfwfaq
🧵Abstract🔽
Via @HECJournal
🖋️Frech, H. E., 3rd, Pauly, M. V., Comanor, W. S., & Martinez, J. R. (2026).
👉Pharmaceutical Pricing and R&D as a Global Public Good.
Health economics, 10.1002/hec.70105.
🌐🔽
https://f.mtr.cool/sltzlfwfaq
🧵Abstract🔽
🖋️Andronis, L., Morgan, C., Donaldson, C., Lancsar, E., & Petrou, S. (2026)
📖 Accounting for the Opportunity Cost of Children's Time in Economic Evaluation: Challenges and Frequently Asked Questions.
Open access 👇
https://f.mtr.cool/wzmtfhwkoo
🧵🔽
🖋️Andronis, L., Morgan, C., Donaldson, C., Lancsar, E., & Petrou, S. (2026)
📖 Accounting for the Opportunity Cost of Children's Time in Economic Evaluation: Challenges and Frequently Asked Questions.
Open access 👇
https://f.mtr.cool/wzmtfhwkoo
🧵🔽
🖋️Špacírová, Z., Rejon-Parrilla, J. C., & Espín, J. (2026).
📖The complex price setting and reimbursement of non-industrial advanced therapy medicinal products.
Health economics review, 10.1186/s13561-026-00732-0.
Open access🌐👇
🖋️Špacírová, Z., Rejon-Parrilla, J. C., & Espín, J. (2026).
📖The complex price setting and reimbursement of non-industrial advanced therapy medicinal products.
Health economics review, 10.1186/s13561-026-00732-0.
Open access🌐👇
🖋️García-Díaz, M., Špacírová, Z., García-Mochón, L., & Espín, J. (2026).
📖 Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review.
1/2
🧵👇
🖋️García-Díaz, M., Špacírová, Z., García-Mochón, L., & Espín, J. (2026).
📖 Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review.
1/2
🧵👇
#ReferenciasAES
@HECJournal
🖋️Gonçalves, J., Costa, E., Hone, T., Singh, D., et al. (2026).
📖 Do Fossil Fuel Subsidies Crowd Out Health Expenditure? A Country-Level Longitudinal Analysis.
Health economics, 35(4), 677–687.
Open access 🌐👇
https://f.mtr.cool/oflmhxyqce
🧵⏬
#ReferenciasAES
@HECJournal
🖋️Gonçalves, J., Costa, E., Hone, T., Singh, D., et al. (2026).
📖 Do Fossil Fuel Subsidies Crowd Out Health Expenditure? A Country-Level Longitudinal Analysis.
Health economics, 35(4), 677–687.
Open access 🌐👇
https://f.mtr.cool/oflmhxyqce
🧵⏬
@HECJournal
🖋️Siciliani, L., Gaughan, J., Gutacker, N., Gravelle, H., & Chalkley, M. (2026).
📖 Paying for Health Gains Using Patient Reported Outcome Measures.
Health economics, 10.1002/hec.70086.
Open access
🌐👇
@HECJournal
🖋️Siciliani, L., Gaughan, J., Gutacker, N., Gravelle, H., & Chalkley, M. (2026).
📖 Paying for Health Gains Using Patient Reported Outcome Measures.
Health economics, 10.1002/hec.70086.
Open access
🌐👇